{"id":2100,"date":"2024-10-07T15:45:28","date_gmt":"2024-10-07T13:45:28","guid":{"rendered":"https:\/\/okuvision.de\/news\/leitlinie-rp\/"},"modified":"2026-05-03T14:28:10","modified_gmt":"2026-05-03T12:28:10","slug":"clinical-guidelines-rp","status":"publish","type":"post","link":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/","title":{"rendered":"Guideline 045\/23: Electrostimulation for Retinitis pigmentosa (RP)"},"content":{"rendered":"

[vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”0″ top_padding=”0″ bottom_padding=”0″ back_color=”color-206913″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ content_parallax=”0″ uncode_shortcode_id=”100151″ back_color_type=”uncode-palette”][vc_column width=”1\/1″]\n

\n \n \n
<\/div>\n \n \n
\n \n
\n
\n \n
\n \n Lesedauer ca. 2 Min. <\/span>\n \n 7. October 2024 <\/span>\n <\/div>\n \n

\n Electrostimulation as a Therapy Option <\/h1>\n \n
\n \n <\/div>\n \n
\n Therapy & Application<\/span>\n Company & Network<\/span>\n Research & Evidence<\/span>\n <\/div>\n \n <\/div>\n \n \n
\n \"Okuvision: <\/div>\n <\/div>\n \n <\/div>\n \n<\/div>\n\n\n[\/vc_column][\/vc_row][vc_row row_height_percent=”0″ override_padding=”yes” h_padding=”2″ top_padding=”3″ bottom_padding=”3″ overlay_alpha=”50″ gutter_size=”3″ column_width_percent=”100″ shift_y=”0″ z_index=”0″ content_parallax=”0″ uncode_shortcode_id=”959669″ row_name=”Einleitung”][vc_column column_width_percent=”70″ gutter_size=”3″ overlay_alpha=”50″ shift_x=”0″ shift_y=”0″ shift_y_down=”0″ z_index=”0″ medium_width=”0″ mobile_width=”0″ width=”1\/1″ uncode_shortcode_id=”705359″][vc_custom_heading heading_semantic=”h3″ text_size=”h3″ uncode_shortcode_id=”151058″]Electrostimulation as a Therapy Option \u2013
Current Ophthalmological Guideline Points to Electrostimulation for Retinitis pigmentosa[\/vc_custom_heading][vc_column_text uncode_shortcode_id=”179329″]In the revision of their Guideline 25 (now Guideline AWMF 045\/23) for Hereditary diseases of the retina, choroid, and optic pathway, the German Ophthalmological Society (DOG), the Retinological Society (RG), and the Professional Association of German Ophthalmologists (BVA) point to electrostimulation as an option for therapy in Retinitis pigmentosa (RP). The study, which began in May as part of the G-BA’s trial study directive, is also mentioned as a possible application context. <\/p>\n

Through the revision of the guideline, ophthalmologists now have concrete courses of action for the symptomatic treatment of hereditary retinal dystrophies with electrostimulation for RP and gene therapy for LCA.<\/p>\n

You can find the original guideline text as a PDF for download:<\/p>\n

\u2013 on the website of the Retinological Society<\/strong>
\n<\/a> \u2013 on the website of the German Ophthalmological Society<\/a><\/strong><\/p>\n

Learn more about the efficacy and safety of OkuStim\u00ae therapy<\/p>\n

To the TES study situation<\/a><\/strong>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

DOG, RG, and BVA name electrostimulation as a therapy option for Retinitis pigmentosa and refer to the G-BA trial study.<\/p>\n","protected":false},"author":10,"featured_media":2101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[176,178,180],"tags":[],"class_list":["post-2100","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-therapy-application","category-company-network","category-research-evidence"],"yoast_head":"\nGuideline 045\/23: Electrostimulation recommended for Retinitis pigmentosa (RP)<\/title>\n<meta name=\"description\" content=\"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\/23). To the guideline text and reference to the G-BA trial study.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guideline 045\/23: Electrostimulation for Retinitis pigmentosa (RP)\" \/>\n<meta property=\"og:description\" content=\"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\/23). To the guideline text and reference to the G-BA trial study.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/\" \/>\n<meta property=\"og:site_name\" content=\"Okuvision\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-07T13:45:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-03T12:28:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2362\" \/>\n\t<meta property=\"og:image:height\" content=\"1575\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Melanie Broll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Melanie Broll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/\"},\"author\":{\"name\":\"Melanie Broll\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\"},\"headline\":\"Guideline 045\\\/23: Electrostimulation for Retinitis pigmentosa (RP)\",\"datePublished\":\"2024-10-07T13:45:28+00:00\",\"dateModified\":\"2026-05-03T12:28:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/\"},\"wordCount\":320,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"articleSection\":[\"Therapy & Application\",\"Company & Network\",\"Research & Evidence\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/\",\"name\":\"Guideline 045\\\/23: Electrostimulation recommended for Retinitis pigmentosa (RP)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"datePublished\":\"2024-10-07T13:45:28+00:00\",\"dateModified\":\"2026-05-03T12:28:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\"},\"description\":\"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\\\/23). To the guideline text and reference to the G-BA trial study.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#primaryimage\",\"url\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"contentUrl\":\"https:\\\/\\\/okuvision.de\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/AdobeStock_1477380325_sw.png\",\"width\":2362,\"height\":1575,\"caption\":\"Okuvision: Doctor's Consultation \u2013 Hands of Patient and Doctor on the Table\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/clinical-guidelines-rp\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guideline 045\\\/23: Electrostimulation for Retinitis pigmentosa (RP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"name\":\"Okuvision\",\"description\":\"\u2013 Sehen erhalten\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/okuvision.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#\\\/schema\\\/person\\\/8c5876ce322b1d535e693245db31cc1b\",\"name\":\"Melanie Broll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g\",\"caption\":\"Melanie Broll\"},\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/news\\\/author\\\/melanie-broll\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guideline 045\/23: Electrostimulation recommended for Retinitis pigmentosa (RP)","description":"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\/23). To the guideline text and reference to the G-BA trial study.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/","og_locale":"en_US","og_type":"article","og_title":"Guideline 045\/23: Electrostimulation for Retinitis pigmentosa (RP)","og_description":"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\/23). To the guideline text and reference to the G-BA trial study.","og_url":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/","og_site_name":"Okuvision","article_published_time":"2024-10-07T13:45:28+00:00","article_modified_time":"2026-05-03T12:28:10+00:00","og_image":[{"width":2362,"height":1575,"url":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","type":"image\/png"}],"author":"Melanie Broll","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Melanie Broll","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#article","isPartOf":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/"},"author":{"name":"Melanie Broll","@id":"https:\/\/okuvision.de\/en\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b"},"headline":"Guideline 045\/23: Electrostimulation for Retinitis pigmentosa (RP)","datePublished":"2024-10-07T13:45:28+00:00","dateModified":"2026-05-03T12:28:10+00:00","mainEntityOfPage":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/"},"wordCount":320,"commentCount":0,"image":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#primaryimage"},"thumbnailUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","articleSection":["Therapy & Application","Company & Network","Research & Evidence"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/","url":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/","name":"Guideline 045\/23: Electrostimulation recommended for Retinitis pigmentosa (RP)","isPartOf":{"@id":"https:\/\/okuvision.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#primaryimage"},"image":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#primaryimage"},"thumbnailUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","datePublished":"2024-10-07T13:45:28+00:00","dateModified":"2026-05-03T12:28:10+00:00","author":{"@id":"https:\/\/okuvision.de\/en\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b"},"description":"DOG, RG, and BVA name electrostimulation as an option for Retinitis pigmentosa (RP) (Guideline 045\/23). To the guideline text and reference to the G-BA trial study.","breadcrumb":{"@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#primaryimage","url":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","contentUrl":"https:\/\/okuvision.de\/wp-content\/uploads\/2021\/10\/AdobeStock_1477380325_sw.png","width":2362,"height":1575,"caption":"Okuvision: Doctor's Consultation \u2013 Hands of Patient and Doctor on the Table"},{"@type":"BreadcrumbList","@id":"https:\/\/okuvision.de\/en\/news\/clinical-guidelines-rp\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okuvision.de\/en\/"},{"@type":"ListItem","position":2,"name":"Guideline 045\/23: Electrostimulation for Retinitis pigmentosa (RP)"}]},{"@type":"WebSite","@id":"https:\/\/okuvision.de\/en\/#website","url":"https:\/\/okuvision.de\/en\/","name":"Okuvision","description":"\u2013 Sehen erhalten","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okuvision.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/okuvision.de\/en\/#\/schema\/person\/8c5876ce322b1d535e693245db31cc1b","name":"Melanie Broll","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ac571fa56fb7caf06fa0a3b99fbe83e949790cb8ce1b8cf70eba98e70e26bd7a?s=96&d=mm&r=g","caption":"Melanie Broll"},"url":"https:\/\/okuvision.de\/en\/news\/author\/melanie-broll\/"}]}},"_links":{"self":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/posts\/2100","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/comments?post=2100"}],"version-history":[{"count":9,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/posts\/2100\/revisions"}],"predecessor-version":[{"id":2533,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/posts\/2100\/revisions\/2533"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/media\/2101"}],"wp:attachment":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/media?parent=2100"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/categories?post=2100"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/tags?post=2100"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}